Inspire Medical Systems (NYSE:INSP – Get Free Report) was upgraded by analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a research report issued on Tuesday, MarketBeat.com reports. The brokerage currently has a $85.00 price target on the stock. Oppenheimer’s target price points to a potential upside of 62.77% from the […]